Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

© 2012 Fernandes et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby...

Full description

Bibliographic Details
Main Author: Fernandes, Isabel (author)
Other Authors: Pacheco, Teresa (author), Costa, Adília (author), Santos, Ana C. (author), Fernandes, Ana R. (author), Santos, Mara (author), Oliveira, António G. (author), Casimiro, Sandra (author), Quintela, António (author), Fernandes, Afonso (author), Ramos, Madalena (author), Costa, Luis (author)
Format: article
Language:eng
Published: 2022
Subjects:
mTOR pathway
Neuroendocrine tumor
Somatostatin analogs
Online Access:http://hdl.handle.net/10451/54617
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/54617

Internet

http://hdl.handle.net/10451/54617

Similar Items